TG-1801
TG-1801-101
Phase 1 small_molecule completed
Quick answer
TG-1801 for B-Cell Lymphoma is a Phase 1 program (small_molecule) at TG THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- B-Cell Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed